Artemis Medicare Services Limited has informed the Exchange about Transcript of Earnings Conference Call Q4 and FY26
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Artemis Medicare reported strong FY26 results with revenue of INR 1,081 crores (15.4% growth) and PAT of INR 104 crores (26.2% growth). Q4 FY26 showed revenue of INR 279 crores with EBITDA margin of 21.3%. The Gurugram flagship hospital operates at 64.6% occupancy with ARPOB of INR 84,571 (up 7.3%). International patients contribute 30-31% of revenue despite Middle East geopolitical challenges. The company plans to expand from 800 to 2,000 beds by 2029, with a 300-bed Raipur hospital starting in Q1 FY27 (expected INR 18-20 crores loss, breakeven in 15-18 months) and a 650-bed South Delhi facility by FY29. Board has approved fundraising up to INR 700 crores for expansion. The company expects 15-17% revenue growth annually with 30% of incremental revenue flowing to EBITDA. Gurugaon EBITDA margins are expected to remain above 20%.
The company demonstrates strong operational performance with margin improvement driven by high-end procedures and international patients. Near-term pressure from Raipur losses (1-1.5% EBITDA drag for ~15 months) will be offset by Gurgaon growth. The expansion roadmap to 2,000 beds by 2029 and INR 700 crore fundraising position the company for sustained growth, though execution risk exists for new facilities.